CVS HEALTH CORPORATION Finite-Lived Intangible Asset, Expected Amortization, Year One
CVS HEALTH CORPORATION (CVS) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $1.72 billion as of 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-10
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.72B.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.98B.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $2.01B.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.60B; Finite-Lived Intangible Asset, Expected Amortization, Year One as first filed $1.62B.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One | Finite-Lived Intangible Asset, Expected Amortization, Year One as first filed |
|---|---|---|
| 2025-12-31 | $1.72B 10-K · filed 2026-02-10 | |
| 2024-12-31 | $1.98B 10-K · filed 2025-02-12 | |
| 2023-12-31 | $2.01B 10-K · filed 2024-02-07 | |
| 2022-12-31 | $1.60B 8-K · filed 2023-05-25 | $1.62B 10-K · filed 2023-02-08 |
| 2021-12-31 | $1.86B 10-K · filed 2022-02-09 | |
| 2020-12-31 | $2.25B 10-K · filed 2021-02-16 | |
| 2019-12-31 | $2.28B 10-K · filed 2020-02-18 | |
| 2018-12-31 | $2.56B 8-K · filed 2019-08-08 | |
| 2017-12-31 | $817.00M 10-K · filed 2018-02-14 | |
| 2016-12-31 | $780.00M 10-K · filed 2017-02-09 | |
| 2015-12-31 | $760.00M 10-K · filed 2016-02-09 | |
| 2014-12-31 | $486.00M 10-K · filed 2015-02-10 | |
| 2013-12-31 | $457.00M 10-K · filed 2014-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |